A Study to Evaluate how Safe and the Body's ability to Tolerate PF-03715455 when Given Twice Daily for 4 Weeks to Subjects with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Femme et Homme

| Pays :
| Organes :
| Spécialités :

Extrait

To determine the effect, at week 4, of orally inhaled PF-03715455 680 micrograms BID on trough FEV1 in subjects with moderate to severe COPD on a stable regimen of short or long acting bronchodilators.

Critère d'inclusion

Chronic Obstructive Pulmonary Disease (COPD)

Liens

euctr